> Skip repeated content
photo of Karmela Kim Chan, MD

Karmela Kim Chan, MD

Rheumatology

About Dr. Chan

loading...
 

Dr. Chan graduated from medical school in the Philippines fully convinced that she wanted to become a rheumatologist. She worked towards that goal, finishing her internal medicine residency at the University of Connecticut and her rheumatology fellowship at the University of Massachusetts.

Before moving to New York City, she spent seven years in private practice in Rhode Island and was Clinical Assistant Professor of Medicine at Brown University, where she saw a broad range of patients with rheumatic conditions. She has a particular clinical interest in inflammatory arthritis, inflammatory eye disease, and SAPHO syndrome. Her research interest is in the rheumatic complications of the immunotherapy of cancer.

Departments

Specialized Centers

Inflammatory Arthritis Center
Integrative Rheumatology and Orthopedics Center

Patient Stories

Patient ratings for Dr. Chan

loading...

Learn more about our patient ratings.

Insurance

Please do not hesitate to contact our office if you have questions regarding your insurance coverage. You may have coverage subject to the availability of 'out-of-network' benefits.

Credentials

Appointments

Assistant Attending Physician, Hospital for Special Surgery
Assistant Attending Physician, Memorial Sloan Kettering Cancer Center
Assistant Professor of Medicine, Weill Cornell Medical College

Education

University of Santo Tomas in Manila, Philippines

Internship

University of Connecticut

Residency

University of Connecticut

Fellowship

University of Massachusetts

Certification

Rheumatology
Internal Medicine

Awards

Top Doctor, Rhode Island Magazine 2015-2016

State Licensure

Languages

English, Tagalog

Publications

Selected Publications

Chan K K, Bass A R. Autoimmune complications of immunotherapy: pathophysiology and management BMJ 2020; 369 :m736 doi:10.1136/bmj.m736

Chan KK, Magro C, Shoushtari A, et al. Eosinophilic Fasciitis Following Checkpoint Inhibitor Therapy: Four Cases and a Review of Literature. Oncologist. 2020;25(2):140-149. doi:10.1634/theoncologist.2019-0508

Reid P, Liew DF, Akruwala R, Bass AR, Chan KK. Activated osteoarthritis following immune checkpoint inhibitor treatment: an observational study. J Immunother Cancer. 2021;9(9):e003260. doi:10.1136/jitc-2021-003260

Chan, K.K., Tirpack, A., Vitone, G., Benson, C., Nguyen, J., Ghosh, N., Jannat-Khah, D., Bykerk, V. and Bass, A.R. (2020), Higher Checkpoint Inhibitor Arthritis Disease Activity may be Associated With Cancer Progression: Results From an Observational Registry. ACR Open Rheumatology, 2: 595-604. https://doi.org/10.1002/acr2.11181

Ghosh, Nilasha MD*,†; Tiongson, Michael D. BA‡; Stewart, Carolyn BA†; Chan, Karmela K. MD*,†; Jivanelli, Bridget MLIS*; Cappelli, Laura MD§; Bass, Anne R. MD*,† Checkpoint Inhibitor–Associated Arthritis, JCR: Journal of Clinical Rheumatology: April 25, 2020 - Volume - Issue -
doi: 10.1097/RHU.0000000000001370 
 

For more publications, please see the PubMed listing.

Research

Industry Relationships

Industry Relationships

One of the goals of HSS is to advance the science of orthopedic surgery, rheumatology, and related disciplines for the benefit of patients. Physicians at HSS may collaborate with outside companies for education, research and medical advances. HSS supports this collaboration in order to foster medical breakthroughs; however HSS also believes that these collaborations must be disclosed.

As part of the disclosure process, this website lists physician collaborations with outside companies. The disclosures are provided by information provided by the physician and other sources and are updated regularly. Further information may be available on individual company websites.

As of December 22, 2020, Dr. Chan reported no relationships with healthcare industry.

By disclosing the collaborations of HSS physicians with industry on this website, HSS and its physicians make this information available to their patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest Policy does not permit physicians to collect royalties on products developed by him/her that are used on patients at HSS.

Dr. Chan in the News